Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial

M A Stokman, F K L Spijkervet, F R Burlage, P U Dijkstra, W L Manson, E G E de Vries, J L N Roodenburg, M A Stokman, F K L Spijkervet, F R Burlage, P U Dijkstra, W L Manson, E G E de Vries, J L N Roodenburg

Abstract

Mucositis is an acute inflammation of the oral mucosa because of radiotherapy and/or chemotherapy. All patients receiving radiotherapy in the head and neck region develop oral mucositis. The aim of this study was to analyse the effects of selective oral flora elimination on radiotherapy-induced oral mucositis, in a double-blind, randomised, placebo-controlled trial. Sixty-five patients with a malignant tumour in the head and neck regions to be treated with primary curative or postoperative radiotherapy participated in this study. The patients received either the active lozenges of 1 g containing polymyxin E 2 mg, tobramycin 1.8 mg and amphotericin B 10 mg (PTA) (33 patients) or the placebo lozenges (32 patients), four times daily during the full course of radiotherapy. Mucositis, changes in the oral flora, quality of feeding and changes of total body weight were assessed. Mucositis score did not differ between the groups during the first 5 weeks of radiotherapy. Nasogastric tube feeding was needed in six patients (19%) of the placebo group and two patients (6%) of the PTA group (P=0.08). Mean weight loss after 5 weeks of radiation was less in the PTA group (1.3 kg) (s.d.: 3.0) than in the placebo group (2.8 kg) (s.d.: 2.9) (P=0.05). Colonisation index of Candida species and Gram-negative bacilli was reduced in the PTA group and not in the placebo group (P<0.05). No effect on other microorganisms was detected. In conclusion, selective oral flora elimination in head and neck irradiation patients does not prevent the development of severe mucositis.

Figures

Figure 1
Figure 1
The mean mucositis score (±s.d.) for the PTA group (▵) and the placebo group (□).
Figure 2
Figure 2
Percentage of patients colonised for Candida species for the PTA group (lines) and the placebo group (solid).
Figure 3
Figure 3
Percentage of patients colonised for aerobic Gram-negative bacilli for the PTA group (lines) and the placebo group (solid).

References

    1. Anonymous (1979) Handbook for Reporting Results of Cancer Treatment, Vol. 48. 15–22. WHO Offset Publication.
    1. Anonymous (1993) ICRU Report 50: Prescribing, Recording and Reporting Photon Beam Therapy. Bethesda, MD: ICRU Publications
    1. Baker DG. (1982) The radiobiological basis for tissue reactions in the oral cavity following therapeutic X-irradiation. A review. Arch Otolaryngol 108: 21–24
    1. Bernhoft CH, Skaug N (1985) Oral findings in irradiated edentulous patients. Int J Oral Surg 14: 416–427
    1. Jansma J, Vissink A, Spijkervet FKL, Roodenburg JLN, Panders AK, Vermey A, Szabo BG, Gravenmade EJ (1992) Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy. Cancer 70: 2171–2180
    1. Kaanders JHAM, Kogel AJvd, Ang KK (1999) Altered fractionation: limited by mucosal reactions? Radiother Oncol 50: 247–260
    1. Kaanders JHAM, Pop LAM, Muytjens HL, Bruaset I, Daal WAJv (1995) Topical administration of antimicrobial agents to prevent irradiation mucositis of the oral cavity and oropharynx: a pilot study. Radiat Oncol Invest 2: 283–290
    1. Miralbell R, Allal AS, Mermillod B, Pastoors B (1999) The influence of field size and other radiotherapy parameters on acute toxicity in pharyngolaryngeal cancers. Strahlenther Onkol 175: 74–77
    1. Okuno SH, Foote RL, Loprinzi CL, Gulavita S, Sloan JA, Earle J, Novotny PJ, Burk M, Frank AR (1997) A randomised trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer 79: 2193–2199
    1. Parulekar W, Mackenzie R, Bjarnason G, Jordan RCK (1998) Scoring oral mucositis. Oral Oncol 34: 63–71
    1. Sonis ST (1998) Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 34: 39–43
    1. Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett Jr WH, Mulagha MT, Peterson DE, Rose AH, Schubert MM, Spijkervet FKL, Wittes JP (1999) Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 85: 2103–2113
    1. Spijkervet FKL, Van Saene HKF, Panders AK, Vermey A (1989a) Colonisation index of the oral cavity: a novel technique for monitoring colonisation defence. Microbial Ecol Health Dis 2: 145–151
    1. Spijkervet FKL, Van Saene HKF, Panders AK, Vermey A, Mehta DM (1989b) Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med 18: 167–171
    1. Spijkervet FKL, Van Saene HKF, Panders AK, Vermey A, Van Saene JJM, Mehta DM, Fidler V (1989c) Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis. Oral Surg Oral Med Oral Pathol 67: 154–161
    1. Spijkervet FKL, Van Saene JJM, Panders AK, Vermey A, Mehta DM (1990) Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients. J Oral Pathol Med 19: 486–489
    1. Sutherland SE, Browman GP (2001) Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomised controlled trials. Int J Radiat Oncol Biol Phys 49: 917–930
    1. Symonds RP, McIlroy P, Khorrami J, Paul J, Pyper E, Alcock SR, McCallum I, Speekenbrink ABJ, McMurray A, Lindemann E, Thomas M (1996) The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial. Br J Cancer 74: 312–317
    1. Van Saene HKF, Martin MV (1990) Do microorganisms play a role in irradiation mucositis? Eur J Clin Microbiol Infect Dis 9: 861–863
    1. Wijers OB, Levendag PC, Harms ER, Gan-Teng AM, Schmitz PI, Hendriks WD, Wilims EB, van der Est H, Visch LL (2001) Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomised study. Int J Radiat Oncol Biol Phys 50: 343–352

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever